The Impact of GLP1 Agonists on Bone Metabolism: A Systematic Review.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The Impact of GLP1 Agonists on Bone Metabolism: A Systematic Review.
- Published In:
- Medicina (Kaunas, Lithuania), 58(2) (2022)
- Authors:
- Daniilopoulou, Ioanna, Vlachou, Eugenia, Lambrou, George I, Ntikoudi, Anastasia, Dokoutsidou, Eleni, Fasoi, Georgia, Govina, Ourania, Kavga, Anna, Tsartsalis, Athanasios N
- Database ID:
- RPEP-06075
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06075APA
Daniilopoulou, Ioanna; Vlachou, Eugenia; Lambrou, George I; Ntikoudi, Anastasia; Dokoutsidou, Eleni; Fasoi, Georgia; Govina, Ourania; Kavga, Anna; Tsartsalis, Athanasios N. (2022). The Impact of GLP1 Agonists on Bone Metabolism: A Systematic Review.. Medicina (Kaunas, Lithuania), 58(2). https://doi.org/10.3390/medicina58020224
MLA
Daniilopoulou, Ioanna, et al. "The Impact of GLP1 Agonists on Bone Metabolism: A Systematic Review.." Medicina (Kaunas, 2022. https://doi.org/10.3390/medicina58020224
RethinkPeptides
RethinkPeptides Research Database. "The Impact of GLP1 Agonists on Bone Metabolism: A Systematic..." RPEP-06075. Retrieved from https://rethinkpeptides.com/research/daniilopoulou-2022-the-impact-of-glp1
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.